Perifosine Akt inhibitor

Keryx And Aeterna Zentaris: 2 Great Buys With Good Odds On FDA Approval
Seeking Alpha
Fri, 10/21/11 - 10:11 am
Keryx
FDA
Aeterna Zentaris
colorectal cancer
Perifosine Akt inhibitor